Search Results - "Latif, Tahir"

Refine Results
  1. 1
  2. 2

    Influence of Rituximab on Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Role of Prophylaxis—A Systematic Review of Prospective Studies by Ghose, Abhimanyu, Elias, Harold Kunal, Guha, Gunjan, Yellu, Mahender, Kundu, Ria, Latif, Tahir

    Published in Clinical lymphoma, myeloma and leukemia (01-08-2015)
    “…Abstract Despite the improvement in overall survival in patients with diffuse large B-cell lymphoma (DLBCL) in the rituximab era, the occurrence of central…”
    Get full text
    Journal Article
  3. 3

    Prophylactic CNS directed therapy in systemic diffuse large B cell lymphoma by Ghose, Abhimanyu, Kundu, Ria, Latif, Tahir

    Published in Critical reviews in oncology/hematology (01-09-2014)
    “…Abstract Overall survival in diffuse large B-cell lymphoma (DLBCL) has significantly improved in the last decade, especially after the incorporation of…”
    Get full text
    Journal Article
  4. 4

    Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles by Blanco, Victor M, Latif, Tahir, Chu, Zhengtao, Qi, Xiaoyang

    Published in Translational oncology (01-06-2015)
    “…Abstract Pancreatic cancer remains one of the most intractable cancers, with a dismal prognosis reflected by a 5-year survival of ~ 6%. Since early disease…”
    Get full text
    Journal Article
  5. 5

    Thalidomide and its analogues in the treatment of Multiple Myeloma by Latif, Tahir, Chauhan, Nabeel, Khan, Rashid, Moran, Andrea, Usmani, Saad Z

    Published in Experimental hematology & oncology (11-09-2012)
    “…Multiple myeloma is an incurable malignant disorder of mature B-cells that predominantly affects the elderly. The immunomodulatory drug (IMiD) thalidomide and…”
    Get full text
    Journal Article
  6. 6

    Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC) by Latif, Tahir, Wood, Laura, Connell, Cindy, Smith, David C, Vaughn, David, Lebwohl, David, Peereboom, David

    Published in Investigational new drugs (01-01-2005)
    “…JM-216 is an orally bioavailable platinum compound with activity against many tumor models. The objective of this study was to determine the safety profile and…”
    Get full text
    Journal Article
  7. 7

    The biology of myelodysplastic syndromes: unity despite heterogeneity by Raza, Azra, Cruz, Raymond, Latif, Tahir, Mukherjee, Siddhartha, Galili, Naomi

    Published in Hematology reports (23-06-2010)
    “…Myelodysplastic syndromes (MDS) traditionally have been grouped together as a disease entity based on clinical phenomena seen in association. Despite the…”
    Get full text
    Journal Article
  8. 8

    Outcomes and prognostic assessment of post-transplant lymphoproliferative disorder by Shaikh, Hira, Omer, Zulfa, Jandarov, Roman, Delman, Aaron, Latif, Tahir

    Published in Journal of clinical oncology (01-06-2022)
    “…e19548 Background: Post-transplant lymphoproliferative disorder (PTLD) is the most common malignancy after solid organ transplantation (SOT) in adults, apart…”
    Get full text
    Journal Article
  9. 9

    Effect of plant spacing on incidence of rice planthoppers in transplanted rice crop by Asghar, Muhammad, Hassan, Talfoor-ul, Arshad, Muhammad, Aziz, Asif, Latif, Muhammad Tahir, Sabir, Arshed Makhdoom

    “…The rice planthoppers (RPHs) are considered as important rice pests in Asia including Pakistan. As phloem-feeders, they can cause severe losses to rice…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Advanced pancreatic cancer outcomes and the impact of COVID-19 pandemic: The experience of an academic cancer center by Adams-Carey, Christian, Shepard, Anna, Moreland, Katie, Olowokure, Olugbenga Olanrele, Latif, Tahir, Rojan, Adam, Pan, Jianmin, Rai, Shesh, Sohal, Davendra

    Published in Journal of clinical oncology (20-01-2024)
    “…626 Background: The COVID-19 pandemic increased all-cause mortality and disrupted healthcare delivery in the United States. Interruptions in cancer screening…”
    Get full text
    Journal Article
  12. 12

    Momelotinib Is a Highly Potent Inhibitor of FLT3-Mutant AML by Azhar, Mohammad, Kincaid, Zachary, Kesarwani, Meenu, Wunderlich, Mark, Latif, Tahir, Starczynowski, Daniel, Azam, Mohammad

    Published in Blood (23-11-2021)
    “…Approximately one-third of AML patients harbor kinase activating mutations in FLT3. Several small-molecule first generation FLT3 tyrosine kinase inhibitors…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Loss of DUSP1 Is Synthetic Lethal to JAK2V617F by Kesarwani, Meenu, Kincaid, Zachary, Latif, Tahir, Azam, Mohammad

    Published in Blood (29-11-2018)
    “…Introduction. Myeloproliferative neoplasm (MPNs) are clonal stem cell disorders characterized by increased production of mature blood cells. Ph-negative MPNs…”
    Get full text
    Journal Article
  17. 17

    Survival outcomes of post-transplant lymphoproliferative disorder: A 12-year analysis by Shaikh, Hira Ghazal, Khan, Rafiullah, Grabel, Michael, Jandarov, Roman, Charif, Mahmoud, Latif, Tahir

    Published in Journal of clinical oncology (20-05-2021)
    “…Abstract only e19543 Background: Post-transplant lymphoproliferative disorder (PTLD) is a rare and potentially fatal complication of chronic immunosuppression…”
    Get full text
    Journal Article
  18. 18

    Pancreatic cancer and diabetes: The effects of race and genes by Shu, Michael, Moreland, Katie, Olowokure, Olugbenga Olanrele, Latif, Tahir, Rojan, Adam, Wilson, Gregory, Patel, Sameer H., Sussman, Jeff, Ahmad, Syed, Pan, Jianmin, Rai, Shesh, Sohal, Davendra

    Published in Journal of clinical oncology (20-01-2024)
    “…627 Background: Pancreatic cancer and diabetes mellitus (DM) have been shown to be connected, but the genetic associations between the two have not been well…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Immune checkpoint inhibitors in liver transplant: a case series by Rudolph, Mark, Shah, Shimul A, Quillin, Ralph, Lemon, Kristina, Olowokure, Olugbenga, Latif, Tahir, Sohal, Davendra

    Published in Journal of gastrointestinal oncology (29-04-2023)
    “…Immune checkpoint inhibitors (ICIs) in the setting of liver transplant (LT) pose a risk of rejection and hold unclear benefit in both the neoadjuvant…”
    Get full text
    Journal Article